Practice of construction safety supervision on the stage I and II B bidding works of TGP

被引：0
|
作者：
Yang, Tian-Min
Li, Pu-Jing
He, Hua-Qiang
机构：
来源：
Renmin Changjiang/Yangtze River | 2002年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
    Kuo, Sung-Hsin
    Lien, Huang-Chun
    You, San-Lin
    Lu, Yen-Shen
    Lin, Ching-Hung
    Chen, T. -Zui
    Huang, Chiun-Sheng
    BREAST, 2008, 17 (06): : 646 - 653
  • [42] Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II, diffuse large B-cell lymphoma of the stomach
    Ishikura, S
    Tobinai, K
    Ohtsu, A
    Nakamura, S
    Yoshino, T
    Oda, I
    Takagi, T
    Mera, K
    Kagami, Y
    Itoh, K
    Tamaki, Y
    Suzumiya, J
    Taniwaki, M
    Yamamoto, S
    CANCER SCIENCE, 2005, 96 (06): : 349 - 352
  • [43] Efficacy and safety of stereotactic radiotherapy on elderly patients with stage I-II central non-small cell lung cancer
    Ji, Xiaoqin
    Zhou, Bin
    Huang, Hua
    Wang, Yong
    Jiang, Wanrong
    Wang, Jiasheng
    Ding, Wei
    Wang, Zhen
    Chen, Guanha
    Sun, Xiangdong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [44] Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study
    Kwon, J. S.
    Carey, M. S.
    Cook, E. F.
    Qiu, F.
    Paszat, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (02) : 433 - 440
  • [45] Treatment of non-small cell lung cancer stage I and stage II - ACCP evidence-based clinical practice guidelines (2nd edition)
    Scott, Walter J.
    Howington, John
    Feigenberg, Steven
    Movsas, Benjamin
    Pisters, Katherine
    CHEST, 2007, 132 (03) : 234S - 242S
  • [46] The role of interferon alfa-2b adjuvant therapy of high risk resected melanoma stage I & II.
    Economou, GK
    Koletsis, EN
    Filopoulos, E
    PROCEEDINGS EUROSURGERY 2000, 2000, : 141 - 144
  • [47] MANAGEMENT OF NODULAR SCLEROSIS HODGKINS-DISEASE STAGE I, II A AND B - EVIDENCE FOR A BENEFICIAL EFFECT OF MOPP ON THE RELAPSE RATE
    LAURIA, F
    BACCARANI, M
    BABINI, L
    EMILIANI, E
    FIACCHINI, M
    GOBBI, M
    MAZZA, P
    SCIASCIA, R
    TURA, S
    ACTA HAEMATOLOGICA, 1979, 62 (5-6) : 262 - 266
  • [48] VACOP-B for stage I/II aggressive non-Hodgkin's lymphoma: Report from the NHLCSG.
    Santini, G
    Salvagno, L
    Majolino, I
    Chisesi, T
    Candela, M
    Olivieri, A
    Tedeschi, L
    Vivaldi, P
    Contu, T
    Coser, P
    Rizzoli, V
    Rubagotti, A
    Endrizzi, L
    Porcellini, A
    De Souza, C
    BLOOD, 2000, 96 (11) : 247B - 247B
  • [49] Safety of Bevacizumab (B) in Elderly Stage IV Non-Squamous NSCLC Patients Selected by Geriatric Assessment: A Phase II Study
    Juan, Oscar
    Aparisi, Francisco
    Llorente, Mar
    Massuti, Bartomeu
    Sanchez-Hernandez, Alfredo
    Martin, Maria
    Blasco Cordellat, Sara
    Blasco, Ana
    Girones, Regina
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S916 - S916
  • [50] Longterm follow-up in semi noma patients stage I and II a/b after adjuvant irradiation of the lymphatic pathways
    Schulz, I
    Röttinger, EM
    Messer, PM
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 54 - 54
12345